Add to ORKGPercutaneous coronary intervention (PCI) is currently the standard of care for patients presenting with acute coronary syndrome (ACS), as well those patients with "stable" angina who have failed medical therapy in whom PCI is an acceptable alternative to surgical revascularization. The aim of adjunctive antiplatelet and antithrombotic therapy during PCI is to alleviate the risks associated with platelet activation and aggregation, iatrogenic plaque rupture, and thrombus formation during. The aim of this review is to summarize the evidence that has emerged from the randomized studies comparing a strategy combining heparin and a glycoprotein IIb/IIIa inhibitor (GPI) with that of bivalirudin in patients undergoing elective and urgent PCI
BACKGROUND: Current guidelines for patients with moderate- or high-risk acute coronary syndromes rec...
BACKGROUND Contrasting evidence exists on the comparative efficacy and safety of bivalirudin and unf...
Acute coronary syndrome (ACS) represents the most common cause of death worldwide. Percutaneous coro...
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
A variety of antithrombotic drugs are used during percutaneous coronary interventions (PCIs). We aim...
In patients undergoing percutaneous coronary intervention (PCI), clinical trials have demonstrated t...
Introduction: Bivalirudin and heparin are the two most commonly used anticoagulants used during Perc...
Percutaneous coronary intervention with bivalirudin plus bail-out glycoprotein IIb/IIIa inhibitors h...
Aims: The aim of the study was to assess the safety and efficacy of Bivalirudin + Glycoprotein (Gp) ...
Introduction: Bivalirudin and heparin are the two most commonly used anticoagulants used during Perc...
Background: The aim of the study was to compare the efficacy and safety of bivalirudin versus unfrac...
Background: The aim of the study was to compare the efficacy and safety of bivalirudin versus unfrac...
AIMS: To evaluate the impact of bivalirudin versus heparin on efficacy and safety outcomes of ST-seg...
BACKGROUND: In the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myo...
BACKGROUND: Current guidelines for patients with moderate- or high-risk acute coronary syndromes rec...
BACKGROUND Contrasting evidence exists on the comparative efficacy and safety of bivalirudin and unf...
Acute coronary syndrome (ACS) represents the most common cause of death worldwide. Percutaneous coro...
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
A variety of antithrombotic drugs are used during percutaneous coronary interventions (PCIs). We aim...
In patients undergoing percutaneous coronary intervention (PCI), clinical trials have demonstrated t...
Introduction: Bivalirudin and heparin are the two most commonly used anticoagulants used during Perc...
Percutaneous coronary intervention with bivalirudin plus bail-out glycoprotein IIb/IIIa inhibitors h...
Aims: The aim of the study was to assess the safety and efficacy of Bivalirudin + Glycoprotein (Gp) ...
Introduction: Bivalirudin and heparin are the two most commonly used anticoagulants used during Perc...
Background: The aim of the study was to compare the efficacy and safety of bivalirudin versus unfrac...
Background: The aim of the study was to compare the efficacy and safety of bivalirudin versus unfrac...
AIMS: To evaluate the impact of bivalirudin versus heparin on efficacy and safety outcomes of ST-seg...
BACKGROUND: In the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myo...
BACKGROUND: Current guidelines for patients with moderate- or high-risk acute coronary syndromes rec...
BACKGROUND Contrasting evidence exists on the comparative efficacy and safety of bivalirudin and unf...
Acute coronary syndrome (ACS) represents the most common cause of death worldwide. Percutaneous coro...